Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.858 |
High Similarity |
NPD3882 |
Suspended |
0.8547 |
High Similarity |
NPD6232 |
Discontinued |
0.8531 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD7473 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8462 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8448 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8448 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8448 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8418 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8412 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8352 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8305 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8286 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8246 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8198 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8187 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8152 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8114 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8103 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.807 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8066 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD919 |
Approved |
0.8035 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7968 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7967 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7966 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7956 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7933 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7923 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7901 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7874 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7841 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7797 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7796 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7701 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7679 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7674 |
Intermediate Similarity |
NPD5401 |
Approved |
0.766 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7609 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7594 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7594 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7584 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7572 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7572 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7569 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7563 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7556 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD943 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7487 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7486 |
Intermediate Similarity |
NPD920 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7471 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7414 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7412 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7411 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7381 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7376 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD37 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7356 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7341 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.734 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7326 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD1240 |
Approved |
0.731 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7292 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7264 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7264 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7214 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7214 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7186 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7158 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7157 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7157 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7157 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7111 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD3764 |
Approved |
0.709 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD7801 |
Approved |
0.705 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.705 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7017 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7011 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7011 |
Intermediate Similarity |
NPD2296 |
Approved |
0.701 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.701 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7005 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7907 |
Approved |
0.6989 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD1933 |
Approved |
0.6963 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD7003 |
Approved |
0.6943 |
Remote Similarity |
NPD7240 |
Approved |
0.6931 |
Remote Similarity |
NPD5242 |
Approved |
0.6928 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6912 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6907 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6901 |
Remote Similarity |
NPD4665 |
Approved |
0.6901 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6895 |
Remote Similarity |
NPD2403 |
Approved |
0.6879 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6878 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6857 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6852 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7095 |
Approved |
0.6842 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD4288 |
Approved |
0.6823 |
Remote Similarity |
NPD2163 |
Approved |
0.6821 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD2354 |
Approved |
0.6806 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD1470 |
Approved |
0.6802 |
Remote Similarity |
NPD411 |
Approved |
0.6802 |
Remote Similarity |
NPD3268 |
Approved |
0.6796 |
Remote Similarity |
NPD7680 |
Approved |
0.6784 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6784 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.678 |
Remote Similarity |
NPD2493 |
Approved |
0.678 |
Remote Similarity |
NPD2494 |
Approved |
0.678
|
Remote Similarity |
NPD3450 |
Approved |